##plugins.themes.bootstrap3.article.main##

Tulasi Naga Subhash Polineni

Aaluri Seenu

Abstract

In this essay, we explore how Subash's contributions to the industry are transforming difficult precision medicine and digital agility concepts into scalable solutions for the healthcare industry. Precision medicine has impacted pharmaceutical and healthcare practices. Digital agility proposes innovative solutions, but it is still a challenge in practice. However, bridging them together aids in addressing real-world challenges that the pharmaceutical and healthcare industries face today. The challenges are: low predictive power of big healthcare data; tracking patient responses and molecular changes; recording elapsed time and required effort; creating alerts; and understanding how to provide individual treatments to long-tail patients who are environmentally and genetically different. Subash has been making original core contributions in theory and practice in both areas. Here, precision medicine with digital agility and assessing proposals have been analyzed with practical data in the healthcare and pharmaceutical industry.
Subash has bridged theoretical knowledge and practical industry equipment for precision medicine, particularly: 1) Epidemic - discrimination between true and false Alzheimer's disease patients in healthcare practice in 2004 and diagnosis of a clinical diagnosis and alcoholics. The former was possible to discriminate between both healthcare data, experimental, and algorithmic considerations.

##plugins.themes.bootstrap3.article.details##